Anudeep Yekula YOU? Author Swipe

Last 10y

EPID-05. PATTERNS OF RECOMMENDATION FOR SURGICAL INTERVENTION IN GRADE II, III, AND IV ASTROCYTOMAS: IMPLICATIONS FOR DELAYED DIAGNOSIS AND TREATMENT Open

Anudeep Yekula, Ping Zhu, Clark Chen · 2023

INTRODUCTION Timely surgical acquisition of tumor tissue for definitive diagnosis forms the foundation for early cancer diagnosis and treatment. Here we examined the pattern of surgical recommendations in the treatment of intracranial astr…

The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring Open

Syeda Maheen Batool, Anudeep Yekula, P. Khanna, Tiffaney Hsia, Austin S. Gamblin , et al. · 2023

The emerging field of liquid biopsy stands at the forefront of novel diagnostic strategies for cancer and other diseases. Liquid biopsy allows minimally invasive molecular characterization of cancers for diagnosis, patient stratification t…

Systematic Review of Photodynamic Therapy in Gliomas Open

Tiffaney Hsia, Julia L. Small, Anudeep Yekula, Syeda M. Batool, A. Escobedo , et al. · 2023

Over the last 20 years, gliomas have made up over 89% of malignant CNS tumor cases in the American population (NIH SEER). Within this, glioblastoma is the most common subtype, comprising 57% of all glioma cases. Being highly aggressive, th…

Systematic review of photodynamic therapy in gliomas Open

Tiffaney Hsia, Julia L. Small, Anudeep Yekula, Syeda Maheen Batool, A. Escobedo , et al. · 2023

Over the last 20 years, gliomas have made up over 89% of malignant CNS tumor cases in the American population (NIH SEER). Within this, glioblastoma is the most common subtype, comprising 57% of all glioma cases. Highly aggressive, this dea…

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Table 1

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Table 3

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Figure 1. (a) Schematic depicting 2D amplitude differentiation between mutually exclusive C228T and C250T mutations

Supplementary File description from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary File Figure legends

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Figure 3. Tumor Tissue Analysis and Analysis of plasma TERT in Copies/mL.

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Figure 2. R-based gating setting and detection of TERT Promoter Mutation in Plasma of Discovery, Validation and Multi-Institution Cohorts

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Table 1

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Figure 2. R-based gating setting and detection of TERT Promoter Mutation in Plasma of Discovery, Validation and Multi-Institution Cohorts

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Table 2

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Figure 1. (a) Schematic depicting 2D amplitude differentiation between mutually exclusive C228T and C250T mutations

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Table 2

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Figure 4. Correlations between (a) progression free survival, (b) overall survival, (c) tumor grade, (d) contrast enhancement, (e) type of TERT mutation, (f) tumor volume, (g) duration of disease, (h) age. Contingency tables …

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Figure 4. Correlations between (a) progression free survival, (b) overall survival, (c) tumor grade, (d) contrast enhancement, (e) type of TERT mutation, (f) tumor volume, (g) duration of disease, (h) age. Contingency tables …

Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Purpose:Liquid biopsy offers a minimally invasive tool to diagnose and monitor the heterogeneous molecular landscape of tumors over time and therapy. Detection of TERT promoter mutations (C228T, C250T) in cfDNA has bee…

Supplementary File description from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary File Figure legends

Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Purpose:Liquid biopsy offers a minimally invasive tool to diagnose and monitor the heterogeneous molecular landscape of tumors over time and therapy. Detection of TERT promoter mutations (C228T, C250T) in cfDNA has bee…

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Figure 3. Tumor Tissue Analysis and Analysis of plasma TERT in Copies/mL.

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Table 3

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Table 1

Supplementary Data from <i>TERT</i> Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas Open

Koushik Muralidharan, Anudeep Yekula, Julia L. Small, Zachary S. Rosh, Keiko M. Kang , et al. · 2023

Supplementary Table 1

Direct stick embolization of a rectal venous malformation via transanal minimally invasive surgery Open

Ryan Bitar, Oluwaseun Ayoade, Anudeep Yekula, Vikram Reddy, Haddon Pantel , et al. · 2023

Rectal venous malformations (VMs) are rare clinical entities with variable patterns of presentation. Treatment requires unique, targeted strategies based on the symptoms, associated complications, and location, depth, and extent of the les…

Neurosurgery Residency Match for International Medical Graduates (IMGs) in the United States (U.S.) Open

Anudeep Yekula, Sattwik Sreeram, Sanjay Dhawan, Mayur Sharma, Carolina Sandoval-Garcia , et al. · 2023

Review question / Objective: Training of international medical graduates (IMGs) offers opportunities for the United States (U.S.) neurosurgery community to engage the global talent pool and impact national and international healthcare.Howe…

Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients Open

Anudeep Yekula, Tiffaney Hsia, Robert R. Kitchen, Sudipto K. Chakrabortty, Wei Yu , et al. · 2023

Background Glioblastoma (GBM) is a highly aggressive and invasive brain tumor associated with high patient mortality. A large fraction of GBM tumors have been identified as epidermal growth factor receptor (EGFR) amplified and ~50% also ar…

Glioblastoma‐derived extracellular vesicle subpopulations following 5‐aminolevulinic acid treatment bear diagnostic implications Open

Tiffaney Hsia, Anudeep Yekula, Syeda Maheen Batool, Yulia B. Rosenfeld, Dong Gil You , et al. · 2022

Liquid biopsy is a minimally invasive alternative to surgical biopsy, encompassing different analytes including extracellular vesicles (EVs), circulating tumour cells (CTCs), circulating tumour DNA (ctDNA), proteins, and metabolites. EVs a…

Single-Cell RNA Sequencing of Cerebrospinal Fluid as an Advanced Form of Liquid Biopsy for Neurological Disorders Open

Anudeep Yekula, Jovanna A. Tracz, Jordina Rincón-Torroella, Tej D. Azad, Chetan Bettegowda · 2022

Diagnosis and longitudinal monitoring of neurological diseases are limited by the poor specificity and limited resolution of currently available techniques. Analysis of circulating cells in cerebrospinal fluid (CSF) has emerged as a promis…

BIOM-12. DEVELOPMENT OF 5-ALA BASED LIQUID BIOPSY FOR THE NON-INVASIVE DIAGNOSIS OF GLIOBLASTOMA Open

Anudeep Yekula, Tiffaney Hsia, Leonora Balaj, Bob S. Carter · 2021

INTRODUCTION Tumor specificity of 5-aminolevulinic acid (5-ALA) induced protoporphyrin IX (PpIX) fluorescence is widely applied for fluorescence-guided surgery (FGS) in gliomas. We recently showed the feasibility of detecting tumour-specif…

Fetching topic information...